ScholarWorks@Korea University College of Medicine: Lee, Kyung-Yeon

Detailed Information

Lee, Kyung-Yeon (이경연)

Guro Hospital (Department of Cardiology, Guro Hospital)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Atrial fibrillation:12||atrial fibrillation:10||Polygenic risk score:2||Cryoablation:2||Alcohol consumption:2||early rhythm control:2||Stroke:2||CHA2DS2VASc Score:1||Cardiac:1||Cardiac pacing, artificial:1||Cause of Death:1||Death:1||Diabetes Mellitus:1||Diabetes mellitus:1||Diagnosis timing:1||Equipment failure:1||Factor Xa inhibitor:1||Fatal ventricular arrhythmia:1||Geneenvironment interaction:1||Genetic predisposition to alcohol metabolism:1||Genetic predisposition to disease:1||Genetic risk:1||Genomewide association study:1||Heart failure:1||Implantable Electrode:1||Ischaemic stroke:1||Korea:1||Leads, cardiac pacemaker:1||Mendelian randomization:1||Neuroticism:1||Offlabel reduced dose:1||Offlabel use:1||Onlabel standard dose:1||Oral anticoagulation:1||Physical activity:1||PopulationBased Study:1||Prognosis:1||Proteinuria:1||Quality of Life:1||Secondhand smoke:1||Sex difference:1||Steatotic liver disease:1||Sudden:1||Sudden cardiac death:1||Type 2 diabetes mellitus:1||Underweight:1||Ventricular fibrillation:1||Ventricular tachycardia:1||angiotensin receptor blocker (ARBs):1||angiotensinconverting enzyme inhibitors (ACEi):1||anticoagulation:1||antihypertensive medication:1||apixaban:1||beta blocker:1||bioelectronics:1||bleeding:1||body mass index:1||burden:1||calcium channel blocker (CCB):1||cancer:1||cancer survivorship:1||cardiac application:1||catheter ablation:1||central obesity:1||clinical characteristics:1||comparative study:1||conduction system pacing left bundle branch area pacing:1||cryoballo on ablation:1||death:1||direct factor Xa inhibitor:1||diuretics:1||dose:1||epidemiology:1||factor Xa inhibitors:1||healthy lifestyle behaviour:1||heart disease:1||hypertension:1||implantable device:1||implantable loop recorder:1||in vivo application:1||liquid metal:1||major adverse cardiovascular events:1||marginal renal function:1||minimally invasive:1||nanocomposite:1||neuroticism:1||offlabel dosing:1||offlabel reduced dose:1||oral anticoagulant:1||outcome:1||perioperative care:1||persistent atrial fibrillation:1||pharmacokinetics:1||physical activity:1||renal dysfunction:1||renal function change:1||right ventricular pacing:1||stroke:1||styletdriven lead:1||treatment outcome:1||Age:1||waist circumference:1||Antiplatelet:1||Antithrombotics:1||Apixaban:1||Atrial Fibrillation:1||Bleeding:1||Body mass index:1||

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE